Sfmg, LLC Eli Lilly & CO Transaction History

Sfmg, LLC

$1.14 Billion
Q2 2024

A detailed history of Sfmg, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Sfmg, LLC holds 3,219 shares of LLY stock, worth $2.4 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

3,219

Previous 3,042 5.82%

Holding current value

$2.4 Million

Previous $2.37 Million 23.16%

% of portfolio

0.26%

Previous 0.21%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $128,301 - $160,900	177 Added 5.82%	3,219 $2.91 Million
Q1 2024 May 07, 2024	SELL	$592.2 - $792.28 $261,160 - $349,395	-441 Reduced 12.66%	3,042 $2.37 Million
Q4 2023 Jan 30, 2024	BUY	$525.19 - $619.13 $234,759 - $276,751	447 Added 14.72%	3,483 $2.03 Million
Q3 2023 Nov 06, 2023	BUY	$434.7 - $599.3 $13,475 - $18,578	31 Added 1.03%	3,036 $1.63 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $2,805 - $3,751	8 Added 0.27%	3,005 $1.41 Million
Q1 2023 May 01, 2023	BUY	$310.63 - $364.82 $34,790 - $40,859	112 Added 3.88%	2,997 $1.03 Million
Q4 2022 Jan 25, 2023	BUY	$321.55 - $374.67 $60,451 - $70,437	188 Added 6.97%	2,885 $0
Q3 2022 Oct 20, 2022	BUY	$296.48 - $337.87 $6,226 - $7,095	21 Added 0.78%	2,697 $875,000
Q2 2022 Aug 08, 2022	BUY	$278.73 - $327.27 $106,753 - $125,344	383 Added 16.7%	2,676 $867,000
Q1 2022 Apr 21, 2022	SELL	$234.69 - $291.66 $101,151 - $125,705	-431 Reduced 15.82%	2,293 $657,000
Q4 2021 Jan 31, 2022	BUY	$224.85 - $279.04 $17,538 - $21,765	78 Added 2.95%	2,724 $752,000
Q3 2021 Nov 01, 2021	BUY	$221.6 - $272.71 $34,126 - $41,997	154 Added 6.18%	2,646 $611,000
Q2 2021 Aug 06, 2021	BUY	$180.55 - $233.54 $10,291 - $13,311	57 Added 2.34%	2,492 $572,000
Q4 2020 Feb 02, 2021	SELL	$130.46 - $172.63 $76,058 - $100,643	-583 Reduced 19.32%	2,435 $411,000
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $160,549 - $185,704	1,098 Added 57.19%	3,018 $447,000
Q1 2020 May 08, 2020	BUY	$119.05 - $147.35 $228,576 - $282,912	1,920 New	1,920 $266,000
Q3 2019 Oct 29, 2019	SELL	$106.79 - $116.16 $308,943 - $336,050	-2,893 Closed	0 $0
Q2 2019 Aug 05, 2019	SELL	$110.79 - $129.32 $495,342 - $578,189	-4,471 Reduced 60.71%	2,893 $313,000
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $90,383 - $106,388	812 Added 12.39%	7,364 $956,000
Q4 2018 Feb 12, 2019	BUY	$105.9 - $118.64 $196,444 - $220,077	1,855 Added 39.49%	6,552 $758,000
Q3 2018 Nov 15, 2018	SELL	$85.86 - $107.31 $343 - $429	-4 Reduced 0.09%	4,697 $501,000
Q2 2018 Aug 08, 2018	BUY	$75.7 - $86.88 $75 - $86	1 Added 0.02%	4,701 $401,000
Q1 2018 May 10, 2018	SELL	$74.21 - $87.6 $20,259 - $23,914	-273 Reduced 5.49%	4,700 $364,000
Q4 2017 Feb 09, 2018	BUY	$81.94 - $87.89 $58,587 - $62,841	715 Added 16.79%	4,973 $420,000
Q3 2017 Nov 07, 2017	BUY	$77.07 - $85.54 $328,164 - $364,229	4,258	4,258 $364,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sfmg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sfmg, LLC with notifications on news.

Account